0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Anti-premature Ejaculation Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-18D14064
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Anti premature Ejaculation Drug Market Research Report 2023
BUY CHAPTERS

Anti-premature Ejaculation Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-18D14064
Report
October 2024
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Anti-premature Ejaculation Drug - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Anti-premature Ejaculation Drug - Market

Anti-premature Ejaculation Drug - Market

The global market for Anti-premature Ejaculation Drug was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti-premature Ejaculation Drug, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Anti-premature Ejaculation Drug by region & country, by Type, and by Application.
The Anti-premature Ejaculation Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-premature Ejaculation Drug.
Market Segmentation

Scope of Anti-premature Ejaculation Drug - Market Report

Report Metric Details
Report Name Anti-premature Ejaculation Drug - Market
CAGR 5%
Segment by Type:
  • Serotonin Reuptake Inhibitors
  • Phosphodiesterase Type 5 Inhibitors
  • Local Anesthetic
  • Others
Segment by Application
  • Hospital
  • Retail Pharmacy
  • Clinic
  • Online Pharmacy
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Menarini Group, Ampio Pharmaceuticals Inc, Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, AdvaCare
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Anti-premature Ejaculation Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Anti-premature Ejaculation Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Anti-premature Ejaculation Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Anti-premature Ejaculation Drug - Market report?

Ans: The main players in the Anti-premature Ejaculation Drug - Market are Menarini Group, Ampio Pharmaceuticals Inc, Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, AdvaCare

What are the Application segmentation covered in the Anti-premature Ejaculation Drug - Market report?

Ans: The Applications covered in the Anti-premature Ejaculation Drug - Market report are Hospital, Retail Pharmacy, Clinic, Online Pharmacy

What are the Type segmentation covered in the Anti-premature Ejaculation Drug - Market report?

Ans: The Types covered in the Anti-premature Ejaculation Drug - Market report are Serotonin Reuptake Inhibitors, Phosphodiesterase Type 5 Inhibitors, Local Anesthetic, Others

1 Market Overview
1.1 Anti-premature Ejaculation Drug Product Introduction
1.2 Global Anti-premature Ejaculation Drug Market Size Forecast
1.2.1 Global Anti-premature Ejaculation Drug Sales Value (2019-2030)
1.2.2 Global Anti-premature Ejaculation Drug Sales Volume (2019-2030)
1.2.3 Global Anti-premature Ejaculation Drug Sales Price (2019-2030)
1.3 Anti-premature Ejaculation Drug Market Trends & Drivers
1.3.1 Anti-premature Ejaculation Drug Industry Trends
1.3.2 Anti-premature Ejaculation Drug Market Drivers & Opportunity
1.3.3 Anti-premature Ejaculation Drug Market Challenges
1.3.4 Anti-premature Ejaculation Drug Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Anti-premature Ejaculation Drug Players Revenue Ranking (2023)
2.2 Global Anti-premature Ejaculation Drug Revenue by Company (2019-2024)
2.3 Global Anti-premature Ejaculation Drug Players Sales Volume Ranking (2023)
2.4 Global Anti-premature Ejaculation Drug Sales Volume by Company Players (2019-2024)
2.5 Global Anti-premature Ejaculation Drug Average Price by Company (2019-2024)
2.6 Key Manufacturers Anti-premature Ejaculation Drug Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Anti-premature Ejaculation Drug Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Anti-premature Ejaculation Drug
2.9 Anti-premature Ejaculation Drug Market Competitive Analysis
2.9.1 Anti-premature Ejaculation Drug Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Anti-premature Ejaculation Drug Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-premature Ejaculation Drug as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Serotonin Reuptake Inhibitors
3.1.2 Phosphodiesterase Type 5 Inhibitors
3.1.3 Local Anesthetic
3.1.4 Others
3.2 Global Anti-premature Ejaculation Drug Sales Value by Type
3.2.1 Global Anti-premature Ejaculation Drug Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Anti-premature Ejaculation Drug Sales Value, by Type (2019-2030)
3.2.3 Global Anti-premature Ejaculation Drug Sales Value, by Type (%) (2019-2030)
3.3 Global Anti-premature Ejaculation Drug Sales Volume by Type
3.3.1 Global Anti-premature Ejaculation Drug Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Anti-premature Ejaculation Drug Sales Volume, by Type (2019-2030)
3.3.3 Global Anti-premature Ejaculation Drug Sales Volume, by Type (%) (2019-2030)
3.4 Global Anti-premature Ejaculation Drug Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Retail Pharmacy
4.1.3 Clinic
4.1.4 Online Pharmacy
4.2 Global Anti-premature Ejaculation Drug Sales Value by Application
4.2.1 Global Anti-premature Ejaculation Drug Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Anti-premature Ejaculation Drug Sales Value, by Application (2019-2030)
4.2.3 Global Anti-premature Ejaculation Drug Sales Value, by Application (%) (2019-2030)
4.3 Global Anti-premature Ejaculation Drug Sales Volume by Application
4.3.1 Global Anti-premature Ejaculation Drug Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Anti-premature Ejaculation Drug Sales Volume, by Application (2019-2030)
4.3.3 Global Anti-premature Ejaculation Drug Sales Volume, by Application (%) (2019-2030)
4.4 Global Anti-premature Ejaculation Drug Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Anti-premature Ejaculation Drug Sales Value by Region
5.1.1 Global Anti-premature Ejaculation Drug Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Anti-premature Ejaculation Drug Sales Value by Region (2019-2024)
5.1.3 Global Anti-premature Ejaculation Drug Sales Value by Region (2025-2030)
5.1.4 Global Anti-premature Ejaculation Drug Sales Value by Region (%), (2019-2030)
5.2 Global Anti-premature Ejaculation Drug Sales Volume by Region
5.2.1 Global Anti-premature Ejaculation Drug Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Anti-premature Ejaculation Drug Sales Volume by Region (2019-2024)
5.2.3 Global Anti-premature Ejaculation Drug Sales Volume by Region (2025-2030)
5.2.4 Global Anti-premature Ejaculation Drug Sales Volume by Region (%), (2019-2030)
5.3 Global Anti-premature Ejaculation Drug Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Anti-premature Ejaculation Drug Sales Value, 2019-2030
5.4.2 North America Anti-premature Ejaculation Drug Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Anti-premature Ejaculation Drug Sales Value, 2019-2030
5.5.2 Europe Anti-premature Ejaculation Drug Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Anti-premature Ejaculation Drug Sales Value, 2019-2030
5.6.2 Asia Pacific Anti-premature Ejaculation Drug Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Anti-premature Ejaculation Drug Sales Value, 2019-2030
5.7.2 South America Anti-premature Ejaculation Drug Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Anti-premature Ejaculation Drug Sales Value, 2019-2030
5.8.2 Middle East & Africa Anti-premature Ejaculation Drug Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Anti-premature Ejaculation Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Anti-premature Ejaculation Drug Sales Value
6.2.1 Key Countries/Regions Anti-premature Ejaculation Drug Sales Value, 2019-2030
6.2.2 Key Countries/Regions Anti-premature Ejaculation Drug Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Anti-premature Ejaculation Drug Sales Value, 2019-2030
6.3.2 United States Anti-premature Ejaculation Drug Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Anti-premature Ejaculation Drug Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Anti-premature Ejaculation Drug Sales Value, 2019-2030
6.4.2 Europe Anti-premature Ejaculation Drug Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Anti-premature Ejaculation Drug Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Anti-premature Ejaculation Drug Sales Value, 2019-2030
6.5.2 China Anti-premature Ejaculation Drug Sales Value by Type (%), 2023 VS 2030
6.5.3 China Anti-premature Ejaculation Drug Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Anti-premature Ejaculation Drug Sales Value, 2019-2030
6.6.2 Japan Anti-premature Ejaculation Drug Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Anti-premature Ejaculation Drug Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Anti-premature Ejaculation Drug Sales Value, 2019-2030
6.7.2 South Korea Anti-premature Ejaculation Drug Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Anti-premature Ejaculation Drug Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Anti-premature Ejaculation Drug Sales Value, 2019-2030
6.8.2 Southeast Asia Anti-premature Ejaculation Drug Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Anti-premature Ejaculation Drug Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Anti-premature Ejaculation Drug Sales Value, 2019-2030
6.9.2 India Anti-premature Ejaculation Drug Sales Value by Type (%), 2023 VS 2030
6.9.3 India Anti-premature Ejaculation Drug Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Menarini Group
7.1.1 Menarini Group Company Information
7.1.2 Menarini Group Introduction and Business Overview
7.1.3 Menarini Group Anti-premature Ejaculation Drug Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Menarini Group Anti-premature Ejaculation Drug Product Offerings
7.1.5 Menarini Group Recent Development
7.2 Ampio Pharmaceuticals Inc
7.2.1 Ampio Pharmaceuticals Inc Company Information
7.2.2 Ampio Pharmaceuticals Inc Introduction and Business Overview
7.2.3 Ampio Pharmaceuticals Inc Anti-premature Ejaculation Drug Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Ampio Pharmaceuticals Inc Anti-premature Ejaculation Drug Product Offerings
7.2.5 Ampio Pharmaceuticals Inc Recent Development
7.3 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
7.3.1 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Company Information
7.3.2 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Introduction and Business Overview
7.3.3 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-premature Ejaculation Drug Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-premature Ejaculation Drug Product Offerings
7.3.5 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Recent Development
7.4 AdvaCare
7.4.1 AdvaCare Company Information
7.4.2 AdvaCare Introduction and Business Overview
7.4.3 AdvaCare Anti-premature Ejaculation Drug Sales, Revenue and Gross Margin (2019-2024)
7.4.4 AdvaCare Anti-premature Ejaculation Drug Product Offerings
7.4.5 AdvaCare Recent Development
8 Industry Chain Analysis
8.1 Anti-premature Ejaculation Drug Industrial Chain
8.2 Anti-premature Ejaculation Drug Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Anti-premature Ejaculation Drug Sales Model
8.5.2 Sales Channel
8.5.3 Anti-premature Ejaculation Drug Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Anti-premature Ejaculation Drug Market Trends
    Table 2. Anti-premature Ejaculation Drug Market Drivers & Opportunity
    Table 3. Anti-premature Ejaculation Drug Market Challenges
    Table 4. Anti-premature Ejaculation Drug Market Restraints
    Table 5. Global Anti-premature Ejaculation Drug Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Anti-premature Ejaculation Drug Revenue Market Share by Company (2019-2024)
    Table 7. Global Anti-premature Ejaculation Drug Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Anti-premature Ejaculation Drug Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Anti-premature Ejaculation Drug Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Anti-premature Ejaculation Drug Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Anti-premature Ejaculation Drug Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Anti-premature Ejaculation Drug
    Table 13. Global Anti-premature Ejaculation Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-premature Ejaculation Drug as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Anti-premature Ejaculation Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Anti-premature Ejaculation Drug Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Anti-premature Ejaculation Drug Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Anti-premature Ejaculation Drug Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Anti-premature Ejaculation Drug Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Anti-premature Ejaculation Drug Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Anti-premature Ejaculation Drug Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Anti-premature Ejaculation Drug Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Anti-premature Ejaculation Drug Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Anti-premature Ejaculation Drug Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Anti-premature Ejaculation Drug Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Anti-premature Ejaculation Drug Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Anti-premature Ejaculation Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Anti-premature Ejaculation Drug Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Anti-premature Ejaculation Drug Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Anti-premature Ejaculation Drug Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Anti-premature Ejaculation Drug Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Anti-premature Ejaculation Drug Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Anti-premature Ejaculation Drug Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Anti-premature Ejaculation Drug Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Anti-premature Ejaculation Drug Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Anti-premature Ejaculation Drug Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Anti-premature Ejaculation Drug Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Anti-premature Ejaculation Drug Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Anti-premature Ejaculation Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Anti-premature Ejaculation Drug Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Anti-premature Ejaculation Drug Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Anti-premature Ejaculation Drug Sales Value by Region (2019-2024) & (%)
    Table 44. Global Anti-premature Ejaculation Drug Sales Value by Region (2025-2030) & (%)
    Table 45. Global Anti-premature Ejaculation Drug Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Anti-premature Ejaculation Drug Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Anti-premature Ejaculation Drug Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Anti-premature Ejaculation Drug Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Anti-premature Ejaculation Drug Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Anti-premature Ejaculation Drug Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Anti-premature Ejaculation Drug Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Anti-premature Ejaculation Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Anti-premature Ejaculation Drug Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Anti-premature Ejaculation Drug Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Anti-premature Ejaculation Drug Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Anti-premature Ejaculation Drug Sales Volume, (2025-2030) & (K Units)
    Table 57. Menarini Group Company Information
    Table 58. Menarini Group Introduction and Business Overview
    Table 59. Menarini Group Anti-premature Ejaculation Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Menarini Group Anti-premature Ejaculation Drug Product Offerings
    Table 61. Menarini Group Recent Development
    Table 62. Ampio Pharmaceuticals Inc Company Information
    Table 63. Ampio Pharmaceuticals Inc Introduction and Business Overview
    Table 64. Ampio Pharmaceuticals Inc Anti-premature Ejaculation Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Ampio Pharmaceuticals Inc Anti-premature Ejaculation Drug Product Offerings
    Table 66. Ampio Pharmaceuticals Inc Recent Development
    Table 67. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Company Information
    Table 68. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Introduction and Business Overview
    Table 69. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-premature Ejaculation Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-premature Ejaculation Drug Product Offerings
    Table 71. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Recent Development
    Table 72. AdvaCare Company Information
    Table 73. AdvaCare Introduction and Business Overview
    Table 74. AdvaCare Anti-premature Ejaculation Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. AdvaCare Anti-premature Ejaculation Drug Product Offerings
    Table 76. AdvaCare Recent Development
    Table 77. Key Raw Materials Lists
    Table 78. Raw Materials Key Suppliers Lists
    Table 79. Anti-premature Ejaculation Drug Downstream Customers
    Table 80. Anti-premature Ejaculation Drug Distributors List
    Table 81. Research Programs/Design for This Report
    Table 82. Key Data Information from Secondary Sources
    Table 83. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anti-premature Ejaculation Drug Product Picture
    Figure 2. Global Anti-premature Ejaculation Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Anti-premature Ejaculation Drug Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Anti-premature Ejaculation Drug Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Anti-premature Ejaculation Drug Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Anti-premature Ejaculation Drug Report Years Considered
    Figure 7. Global Anti-premature Ejaculation Drug Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Anti-premature Ejaculation Drug Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-premature Ejaculation Drug Revenue in 2023
    Figure 10. Anti-premature Ejaculation Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Serotonin Reuptake Inhibitors Picture
    Figure 12. Phosphodiesterase Type 5 Inhibitors Picture
    Figure 13. Local Anesthetic Picture
    Figure 14. Others Picture
    Figure 15. Global Anti-premature Ejaculation Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Anti-premature Ejaculation Drug Sales Value Market Share by Type, 2023 & 2030
    Figure 17. Global Anti-premature Ejaculation Drug Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 18. Global Anti-premature Ejaculation Drug Sales Volume Market Share by Type, 2023 & 2030
    Figure 19. Global Anti-premature Ejaculation Drug Price by Type (2019-2030) & (US$/Unit)
    Figure 20. Product Picture of Hospital
    Figure 21. Product Picture of Retail Pharmacy
    Figure 22. Product Picture of Clinic
    Figure 23. Product Picture of Online Pharmacy
    Figure 24. Global Anti-premature Ejaculation Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 25. Global Anti-premature Ejaculation Drug Sales Value Market Share by Application, 2023 & 2030
    Figure 26. Global Anti-premature Ejaculation Drug Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 27. Global Anti-premature Ejaculation Drug Sales Volume Market Share by Application, 2023 & 2030
    Figure 28. Global Anti-premature Ejaculation Drug Price by Application (2019-2030) & (US$/Unit)
    Figure 29. North America Anti-premature Ejaculation Drug Sales Value (2019-2030) & (US$ Million)
    Figure 30. North America Anti-premature Ejaculation Drug Sales Value by Country (%), 2023 VS 2030
    Figure 31. Europe Anti-premature Ejaculation Drug Sales Value (2019-2030) & (US$ Million)
    Figure 32. Europe Anti-premature Ejaculation Drug Sales Value by Country (%), 2023 VS 2030
    Figure 33. Asia Pacific Anti-premature Ejaculation Drug Sales Value (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Anti-premature Ejaculation Drug Sales Value by Country (%), 2023 VS 2030
    Figure 35. South America Anti-premature Ejaculation Drug Sales Value (2019-2030) & (US$ Million)
    Figure 36. South America Anti-premature Ejaculation Drug Sales Value by Country (%), 2023 VS 2030
    Figure 37. Middle East & Africa Anti-premature Ejaculation Drug Sales Value (2019-2030) & (US$ Million)
    Figure 38. Middle East & Africa Anti-premature Ejaculation Drug Sales Value by Country (%), 2023 VS 2030
    Figure 39. Key Countries/Regions Anti-premature Ejaculation Drug Sales Value (%), (2019-2030)
    Figure 40. Key Countries/Regions Anti-premature Ejaculation Drug Sales Volume (%), (2019-2030)
    Figure 41. United States Anti-premature Ejaculation Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 42. United States Anti-premature Ejaculation Drug Sales Value by Type (%), 2023 VS 2030
    Figure 43. United States Anti-premature Ejaculation Drug Sales Value by Application (%), 2023 VS 2030
    Figure 44. Europe Anti-premature Ejaculation Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Europe Anti-premature Ejaculation Drug Sales Value by Type (%), 2023 VS 2030
    Figure 46. Europe Anti-premature Ejaculation Drug Sales Value by Application (%), 2023 VS 2030
    Figure 47. China Anti-premature Ejaculation Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 48. China Anti-premature Ejaculation Drug Sales Value by Type (%), 2023 VS 2030
    Figure 49. China Anti-premature Ejaculation Drug Sales Value by Application (%), 2023 VS 2030
    Figure 50. Japan Anti-premature Ejaculation Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 51. Japan Anti-premature Ejaculation Drug Sales Value by Type (%), 2023 VS 2030
    Figure 52. Japan Anti-premature Ejaculation Drug Sales Value by Application (%), 2023 VS 2030
    Figure 53. South Korea Anti-premature Ejaculation Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 54. South Korea Anti-premature Ejaculation Drug Sales Value by Type (%), 2023 VS 2030
    Figure 55. South Korea Anti-premature Ejaculation Drug Sales Value by Application (%), 2023 VS 2030
    Figure 56. Southeast Asia Anti-premature Ejaculation Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 57. Southeast Asia Anti-premature Ejaculation Drug Sales Value by Type (%), 2023 VS 2030
    Figure 58. Southeast Asia Anti-premature Ejaculation Drug Sales Value by Application (%), 2023 VS 2030
    Figure 59. India Anti-premature Ejaculation Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 60. India Anti-premature Ejaculation Drug Sales Value by Type (%), 2023 VS 2030
    Figure 61. India Anti-premature Ejaculation Drug Sales Value by Application (%), 2023 VS 2030
    Figure 62. Anti-premature Ejaculation Drug Industrial Chain
    Figure 63. Anti-premature Ejaculation Drug Manufacturing Cost Structure
    Figure 64. Channels of Distribution (Direct Sales, and Distribution)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Drugs to Treat Hypertriglyceridemia - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-37P13132
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Add to Cart

Medications for Actinic Keratosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-36R13742
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Melatonin API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-21J13714
Wed Nov 06 00:00:00 UTC 2024

Add to Cart